|
| Analysis population (N = 507) |
| Age, years, mean (SD) | 58.8 (10.7) |
| Male sex, n (%) | 404 (79.7) |
| Body mass index ≥ 30 kg/m2 (obesity), n (%) | 115 (22.7) |
| Smoking, n (%) | 203 (40.0) |
| Arterial hypertension, n (%) | 227 (44.8) |
| Diabetes, n (%) | 273 (53.9) |
| Renal failure, n (%) | 89 (17.6) |
| LDL-cholesterol > 1 g/L, n (%) | 266 (52.4) |
| Low HDL-cholesterol, n (%) | 310 (61.1) |
| Dyslipidemia, n (%) | 54 (10.7) |
| Lipid-lowering treatment (statins), n (%) | 42 (8.3) |
| History of coronary disease, n (%) |
|
| Stable angor | 36 (7.1) |
| Myocardial infarction | 25 (4.9) |
| Unstable angor | 8 (1.6) |
| Family history of early coronary artery disease, n (%) | 57 (11.2) |
| History of stroke/transient ischemic attack, n (%) | 9 (1.8) |
| Left ventricular dysfunction, n (%) | 192 (47.5) |
| Framingham score > 20%, n (%) | 83 (16.4) |
| High risk European score, n (%) | 222 (63.6) |
| Reasons for coronary angiography, n (%) |
|
| Acute coronary syndrome |
|
| ST-segment elevation myocardial infarction (STMI) | 238 (46.9) |
| Non-ST-segment elevation myocardial infarction (NSTMI) | 193 (38.1) |
| Post-myocardial infarction | 23 (4.5) |
| Exploration |
|
| Exercise-induced angina | 33 (6.5) |
| Positive ischemia test | 41 (8.0) |
| Preoperative workup | 8 (1.5) |
| Dilated or obstructive cardiomyopathy | 6 (1.1) |
| Silent ischemia | 1 (0.2) |